Recombinant Human C4BPB protein (rFc Tag)
Species
Human
Purity
>90 %, SDS-PAGE
Tag
rFc Tag
Activity
not tested
Cat no : Eg2976
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human C4BPB protein Ser18-Leu252 (Accession# P20851-1) with a rabbit IgG Fc tag at the C-terminus. |
GeneID | 725 |
Accession | P20851-1 |
PredictedSize | 52.4 kDa |
SDS-PAGE | 57-80 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Complement 4 binding protein beta chain (C4BPB) is one of the two polypeptides that in humans compose plasma glycoprotein C4b-binding protein (C4BP). C4BPB binds anticoagulant vitamin K-dependent S. C4BPB controls the classical pathway of complement activation. It binds as a cofactor to the C3b/C4b inactivator (C3bINA), hydrolyzing the complement fragment C4b. It also accelerates the degradation of the C4bC2a complex (C3 convertase) by dissociating the complement fragment C2a.
References:
1.Rodríguez de Córdoba S. et al. (1994) Genomics. 21(3):501-509. 2.Kadavá T. et al. (2024) EMBO J. 43(14):3009-3026.